Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Concurrent mutations in other epigenetic modulators portend better prognosis in BCOR-mutated myelodysplastic syndrome.

Journal of clinical pathology - 1 Apr 2020

Badaat Ibraahim, Mirza Sabbir, Padron Eric, Sallman David, Komrokji Rami, Song Jinming, Hussaini Mohammad O

Abstract excerpt

INTRODUCTION: The role of single mutations has been extensively studied myelodysplastic syndromes (MDS), but the impact of genetic aberrations in the context of other mutations is less well understood. BCOR is an epigenetic transcriptional corepressor. In MDS, BCOR mutations are rare and certain mutations are associated with poor prognosis. Our aim was to investigate the role of concurrent mutations in epigenetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epigenesis, Genetic

Share to Myelodysplastic Syndromes

Share to Neoplasm Proteins

Share to Prognosis

Share to Proto-Oncogene Proteins

Share to Repressor Proteins

Source

Identifiers

PMID: 31771970
DOI: 10.1136/jclinpath-2019-206132

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Concurrent mutations in other epigenetic modulators portend better prognosis in BCOR-mutated myelodysplastic syndrome.PMID 31771970Read ↗

Dynamics of epigenetic regulator gene BCOR mutation and response predictive value for hypomethylating agents in patients with myelodysplastic syndrome.Semantic proximity Read ↗

BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.Semantic proximity Read ↗

Genetic landscape and clinical outcomes of patients with BCOR mutated myeloid neoplasms.Semantic proximity Read ↗

[Clinical Characteristics and Prognostic Significance of BCOR/BCORL1 Gene Mutation in Patients with Myelodysplastic Syndromes].Semantic proximity Read ↗

Analysis of core mutation and TET2/ASXL1 mutations DNA methylation profile in myelodysplastic syndrome.Semantic proximity Read ↗

Prognostic impact of DTA mutation and co-occurring mutations in patients with myelodysplastic syndrome.Semantic proximity Read ↗

Bcor insufficiency promotes initiation and progression of myelodysplastic syndromeSemantic proximity Read ↗

[Molecular and clinical characteristics and prognosis of myelodysplastic neoplasms with biallelic TET2 inactivation].Semantic proximity Read ↗

Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study.Semantic proximity Read ↗

Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients.Semantic proximity Read ↗

The clinical implications of BCOR mutations in a large cohort of acute myeloid leukemia patients: a 5-year single-center retrospective study.Semantic proximity Read ↗

Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotypeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.